ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism.

By A. Berg, Terry P. Combs, P. Scherer. Trends in endocrinology and metabolism, 2002

1,240 citations recorded by the source corpus.

Subfields: Epidemiology, Molecular Biology, Physiology

View Paper: https://www.semanticscholar.org/paper/faac9dcc035eb7b56af8009b9bbac7ebe93fbbab

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Herbert Tilg
2. A. Moschen
3. P. Scherer
4. M. Trujillo
5. H. Lodish
6. Philippe Froguel
7. H. Ruan
8. I. Wolowczuk

In Molecular Biology

1. M. Trujillo
2. H. Lodish
3. H. Ruan
4. Philippe Froguel
5. Herbert Tilg
6. A. Moschen
7. I. Wolowczuk
8. Kassem Makki

In Physiology

1. Herbert Tilg
2. M. Trujillo
3. A. Moschen
4. H. Lodish
5. H. Ruan
6. P. Scherer
7. Philippe Froguel
8. Kassem Makki

Citations in the corpus

• Adiponectin Regulation and Function (2018, neutral): “Adiponectin is a 30-kDa monomeric glycoprotein (14).”
• Mammalian hibernation: cellular and molecular responses to depressed metabolism and low temperature. (2003, background): “Another potent physiological effector secreted from adipocytes, adiponectin, has not yet been studied in hibernators, but it is intriguing that it is homologous to proteins first identified as declining during hibernation in Siberian chipmunks, HP-20, HP-25, and HP-27 (21).”
• Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. (2003, background): “Recent studies have yielded somewhat controversial results, and the data collected by independent groups have been confounded by the differences in the preparations of the Acrp30 protein and in the oligomerization states of the protein [94].”
• Adipose tissue-derived factors: impact on health and disease. (2006, background): “Adiponectin is composed of an N-terminal signal sequence, a hypervariable domain, 15 collagenous repeats, and a C-terminal globular domain (84).”
• The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. (2003, positive): “Discussion Recent studies from several independent laboratories have demonstrated that adiponectin and its agonists could be promising candidates for the treatment of obesity-associated metabolic syndromes (17).”
• Adiponectin: action, regulation and association to insulin sensitivity (2005, background): “A novel serum protein similar to C1q, produced exclusively in adipocytes.”
• Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes (2008, background): “Two crucial roles of adipose tissue seem to contribute to this function: the secretion of appropriate levels of adipokines, which influence both whole-body metabolism and neuroendocrine control of behaviours that are related to feedin”
• Adipocytokines: mediators linking adipose tissue, inflammation and immunity (2006, background): “In obese animals, treatment with adiponectin decreases hyperglycaemia and levels of free fatty acids in the plasma, and improves insulin sensitivit”